3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Upfront autologous HSCT - Systemic Sclerosis, Systemic Scleroses, Diffuse | Phase 4 | Completed | UMC Utrecht | 60 | 2020-09-17 | 2026-03-24 |
| Pulmonary Artery Remodelling With Bosentan bosentan - Hypertension, Pulmonary | Phase 4 | Completed | Actelion | 11 | 2006-05-31 | 2026-06-03 |
| Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon Pletal - Raynaud's Disease | Phase 4 | Completed | Otsuka America Pharmaceutical | 75 | 2001-10-01 | 2005-07-19 |
Hypertension (1) · Hypertension, Pulmonary (1) · Mixed Connective Tissue Disease (1) · Raynaud Disease (1) · Scleroderma, Systemic (1) · Sclerosis (1)
Connective Tissue Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Cardiovascular Diseases (2) · Scleroderma, Systemic (2) · Vascular Diseases (2) · Embolism and Thrombosis (1) · Livedoid Vasculopathy (1) · Lung Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Vascular Diseases (1) · Respiratory Tract Diseases (1) · Skin Diseases, Vascular (1) · Thrombosis (1)
Bosentan (1) · Cilostazol (1)
Actelion (1) · Otsuka America Pharmaceutical (1) · UMC Utrecht (1)
Australia (1) · Italy (1) · Netherlands (1) · United Kingdom (1) · United States (1)
David Celermajer, Professor (1) · Jacob M van Laar, MD PhD (1) · Julia Spierings (1)